α-1 antitrypsin PI MZ heterozygotes have reduced lung function in two large cohorts

I. C. Sørheim, P. Bakke, A. Gulsvik, A. Johannessen, S. G. Pillai, P. I. Gaarder, E. J. Campbell, H. Coxson, D. A. Lomas, C. P. Hersh, E. K. Silverman, International COPD Genetics Network (ICGN) Investigators (Boston, North Carolina, Salt Lake City, United States Of America; Bergen, Oslo, Norway; Vancouver, Canada; Cambridge, United Kingdom)

Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD
Session: Environmental and genetic risk factors for asthma and COPD
Session type: Oral Presentation
Number: 399
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. C. Sørheim, P. Bakke, A. Gulsvik, A. Johannessen, S. G. Pillai, P. I. Gaarder, E. J. Campbell, H. Coxson, D. A. Lomas, C. P. Hersh, E. K. Silverman, International COPD Genetics Network (ICGN) Investigators (Boston, North Carolina, Salt Lake City, United States Of America; Bergen, Oslo, Norway; Vancouver, Canada; Cambridge, United Kingdom). α-1 antitrypsin PI MZ heterozygotes have reduced lung function in two large cohorts. Eur Respir J 2009; 34: Suppl. 53, 399

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
21 year follow-up of pulmonary function and disease in α 1-antitrypsin MZ heterozygotes
Source: Eur Respir J 2001; 18: Suppl. 33, 152s
Year: 2001

SERPINA1 MS and MZ heterozygotes and lung function decline in the SAPALDIA cohort study
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010


Comparison between population with severe (ZZ) and intermediate (MZ) alpha1-antitrypsin deficiency and established COPD
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients
Source: Annual Congress 2008 - COPD
Year: 2008


SERPINA1 gene variants in subjects from a general population with reduced alpha1-antitrypsin level
Source: Annual Congress 2008 - COPD
Year: 2008


Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles
Source: Eur Respir J 2004; 24 : 798-804
Year: 2004



COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
Source: Eur Respir Rev, 26 (146) 170068; 10.1183/16000617.0068-2017
Year: 2017



Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

MRP1 polymorphisms contribute to level and decline of lung function in two general population cohorts
Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD
Year: 2008



Frequency of α-1 antitrypsin deficiency (AATD) in a population screening in an high risk area (Val Trompia, Italy)
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006

Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017
Year: 2017



GSTT1 null alleles are risk factors for excess FEV1 decline in the general population, but GSTM1 null alleles only in smokers
Source: Eur Respir J 2007; 30: Suppl. 51, 447s
Year: 2007

Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD).
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021


Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Epithelial cell biology
Year: 2010



Relationship between parental lung function and their children’s lung function early in life
Source: Eur Respir J 2011; 38: 664-671
Year: 2011



HLA class II alleles are associated with development of emphysema in alpha-1-antitrypsin deficiency (AATD)
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


The prognostic value of CT-based lung density histograms in patients with severe alpha-1 antitrypsin deficiency
Source: Eur Respir J 2004; 24: Suppl. 48, 296s
Year: 2004